Skip to main content
Testing version — LOERadar is in active testing. Features and data may change.
LOERadar
LOE
Radar
Hub
News
Changes
Search
Log in
Get Started
ARTESUNATE (ARTESUNATE) | LOERadar
Viewing data from:
Latest
2026-07-01
2026-06-01
2026-05-01
2026-04-01
2026-03-28
2026-02-17
2026-02-10
2025-12-14
2025-02-26
2025-01-25
2024-11-08
2023-07-23
2023-06-15
2023-05-13
2023-01-26
2022-11-22
2022-10-28
2022-09-29
2022-07-09
2022-06-29
2022-04-08
2022-03-09
2021-12-28
2021-05-05
2021-03-12
2020-12-22
2020-11-12
2019-12-14
2019-09-15
ARTESUNATE
NDA
Get alerts
ARTESUNATE | N213036 | AMIVAS INC
1 strength
2 unique patents
1 unique exclusivity
Patents
SEC Intel
Revenue
PTAB
Reexams
Litigation
Petitions
Trials
DMF
Approvals
Label
Products
Patent Timeline
2 unique patents, 1 exclusivity by expiration date
Active (2)
Today
Exclusivity
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
Today
12121506
Feb. 16, 2044
12390442
Feb. 16, 2044
ODE-290
May. 26, 2027
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
No ANDA patent litigation cases (NOS 835) matched from PACER
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (1)
#001 — 110MG/VIAL
RLD
2 patents
1 exclusivity
▴
POWDER;INTRAVENOUS | Approved: May 26, 2020
Patents (2)
Patent #
Expiration
PED
Drug Substance
Drug Product
Use Code
Delist
12121506
Feb 16, 2044
—
—
Yes
—
—
12390442
Feb 16, 2044
—
—
—
U-4433
—
Exclusivities (1)
Code
Date
Status
ODE-290
May 26, 2027
< 1 year